214194-00-0

Basic information

• Product Name: (8R,9R)-8-hydroxy-2,3-dimethyl-9-phenyl-9,10-dihydro-8H-imidazo[1,2-h][1,7]naphthyridin-7-one
• CAS NO: 214194-00-0
• Molecular Formula: C₁₈H₁₇N₃O₂
• Molecular Weight: 307.35
• Mol File: 214194-00-0.mol
• Article Data: 4

Chemical Properties

• Density: 1.38g/cm³
• Refractive Index: 1.712
• CAS DataBase Reference: (8R,9R)-8-hydroxy-2,3-dimethyl-9-phenyl-9,10-dihydro-8H-imidazo[1,2-h][1,7]naphthyridin-7-one(CAS DataBase Reference)
• NIST Chemistry Reference: (8R,9R)-8-hydroxy-2,3-dimethyl-9-phenyl-9,10-dihydro-8H-imidazo[1,2-h][1,7]naphthyridin-7-one(214194-00-0)
• EPA Substance Registry System: (8R,9R)-8-hydroxy-2,3-dimethyl-9-phenyl-9,10-dihydro-8H-imidazo[1,2-h][1,7]naphthyridin-7-one(214194-00-0)

Safety Data

• Hazardous Substances Data: 214194-00-0(Hazardous Substances Data)

Usage

General Description

(8R,9R)-8-hydroxy-2,3-dimethyl-9-phenyl-9,10-dihydro-8H-imidazo[1,2-h][1,7]naphthyridin-7-one is a chemical compound with a complex structure. It contains a hydroxy group, two methyl groups, and a phenyl group, as well as an imidazo and naphthyridin ring system. It has a chiral center with a stereochemistry of (8R,9R). (8R,9R)-8-hydroxy-2,3-dimethyl-9-phenyl-9,10-dihydro-8H-imidazo[1,2-h][1,7]naphthyridin-7-one may have potential pharmaceutical applications due to its unique structure, such as serving as a building block in drug discovery or as a potential therapeutic agent in its own right. Further research and investigation are likely needed to fully understand and unlock the potential of this compound.

Upstream product

• 214194-14-6 N-(2,3-dimethylimidazo[1,2-a]pyridin-8-yl)-2,2-dimethylpropanamide 
• 717884-33-8 7-(t-butyl-dimethyl-silanoxy)-2,3-dimethyl-8-phenyl-8,9-dihydro-7H-1,3a,9-triaza-cyclopenta[a]naphthalen-6-one 

Downstream Products

• 261944-33-6 (7S,8R,9R)-2,3-Dimethyl-8-hydroxy-7-methoxy-9-phenyl-7,8,9,10-tetrahydro-imidazo[1,2-h]-[1,7]naphthyridine 
• 214194-01-1 (7R,8R,9R)-2,3-dimethyl-7,8-dihydroxy-9-phenyl-7,8,9,10-tetrahydro-imidazo[1,2-h][1,7]naphthyridine 
• 214194-02-2 (7S,8R,9R)-2,3-Dimethyl-7,8-dihydroxy-9-phenyl-7,8,9,10-tetrahydro-imidazo[1,2-h][1,7]naphthyridine 
• 261944-46-1 (7R,8R,9R)-2,3-dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo[1,2-h][1,7]naphthyridine 
• 261944-51-8 (7S,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo[1,2-h][1,7]naphthyridine 
• 261944-24-5 (7R,8R,9R)-2,3-dimethyl-8-hydroxy-7-methoxy-9-phenyl-7,8,9,10-tetrahydro-imidazo[1,2-h][1,7]naphthyridine 
• 364041-30-5 (7R,8R,9R)-2,3,7-Trimethyl-7,8-dihydroxy-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]-naphthyridine 
• 364041-23-6 (8S,9R)-2,3,8-trimethyl-8-hydroxy-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-7-one 

Relevant articles and documents

TETRAHYDROPYRIDOETHERS FOR THE TREATMENT OF STARGARDT'S DISEASE

A pharmaceutical composition comprising tetrahydropyridoethers for treatment of Stargardt's disease.

Tetrahydropyridoethers

Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.